CCDC45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.636400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.460410E-01
Normal-vs-Stage2
7.374500E-02
Normal-vs-Stage3
9.338500E-02
Normal-vs-Stage4
3.497400E-01
Stage1-vs-Stage2
5.298800E-01
Stage1-vs-Stage3
4.289200E-01
Stage1-vs-Stage4
5.736000E-01
Stage2-vs-Stage3
1.896640E-01
Stage2-vs-Stage4
8.811200E-01
Stage3-vs-Stage4
1.979640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.119800E-02
Normal-vs-AfricanAmerican
5.657800E-01
Normal-vs-Asian
1.976590E-01
Caucasian-vs-AfricanAmerican
2.662400E-01
Caucasian-vs-Asian
7.102600E-01
AfricanAmerican-vs-Asian
5.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.173500E-02
Normal-vs-Female
9.492400E-02
Male-vs-Female
5.657800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.898600E-01
Normal-vs-Age(41-60Yrs)
1.471240E-01
Normal-vs-Age(61-80Yrs)
4.474300E-02
Normal-vs-Age(81-100Yrs)
3.243400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.063800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.800000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.816200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.459800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.837160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.257900E-02
Normal-vs-Daily Drinker
8.274000E-02
Normal-vs-Weekly Drinker
3.100400E-01
Normal-vs-Occasional Drinker
1.426810E-01
Normal-vs-Social Drinker
3.459400E-01
Non Drinker-vs-Daily Drinker
9.794400E-01
Non Drinker-vs-Weekly Drinker
8.021800E-01
Non Drinker-vs-Occasional Drinker
5.775600E-01
Non Drinker-vs-Social Drinker
6.814200E-02
Daily Drinker-vs-Weekly Drinker
8.558600E-01
Daily Drinker-vs-Occasional Drinker
6.302200E-01
Daily Drinker-vs-Social Drinker
1.271440E-01
Weekly Drinker-vs-Occasional Drinker
5.060000E-01
Weekly Drinker-vs-Social Drinker
7.923800E-02
Occasional Drinker-vs-Social Drinker
3.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.417800E-01
Normal-vs-Grade 2
1.384380E-01
Normal-vs-Grade 3
8.475500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.600800E-01
Grade 1-vs-Grade 3
1.442580E-01
Grade 1-vs-Grade 4
2.417800E-01
Grade 2-vs-Grade 3
1.962810E-01
Grade 2-vs-Grade 4
1.384380E-01
Grade 3-vs-Grade 4
8.475500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.821400E-01
Normal-vs-NonDiabetic
1.338020E-01
Diabetic-vs-NonDiabetic
4.938100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.898400E-01
Normal-vs-NoPancreatitis
3.705900E-02
Pancreatitis-vs-NoPancreatitis
2.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.239970E-01
Normal-vs-N1
4.690400E-02
N0-vs-N1
3.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.698560E-01
Normal-vs-TP53-NonMutant
1.687980E-01
TP53-Mutant-vs-TP53-NonMutant
9.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
